BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonaccorsi-riani E, Brüggenwirth I, Buchwald J, Iesari S, Martins P. Machine Perfusion: Cold versus Warm, versus Neither. Update on Clinical Trials. Semin Liver Dis 2020;40:264-81. [DOI: 10.1055/s-0040-1713118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lascaris B, de Meijer VE, Porte RJ. Normothermic liver machine perfusion as a dynamic platform for regenerative purposes. What does the future have in store for us? Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.04.033] [Reference Citation Analysis]
2 Amin A, Ripa V, Paterno F, Guarrera JV. Support for Ex Vivo Organ Perfusion in Kidney and Liver Transplantation. Curr Transpl Rep 2021;8:333-43. [DOI: 10.1007/s40472-021-00347-w] [Reference Citation Analysis]
3 Bonaccorsi-Riani E, Gillooly A, Brüggenwirth IM, Martins PN. Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00075-8. [PMID: 33958293 DOI: 10.1016/j.hbpd.2021.04.006] [Reference Citation Analysis]
4 Brüggenwirth IMA, Lantinga VA, Rayar M, van den Berg AP, Blokzijl H, Reyntjens KMEM, Porte RJ, de Meijer VE; DHOPE-PRO Trial Investigators. Prolonged dual hypothermic oxygenated machine preservation (DHOPE-PRO) in liver transplantation: study protocol for a stage 2, prospective, dual-arm, safety and feasibility clinical trial. BMJ Open Gastroenterol 2022;9:e000842. [PMID: 35039326 DOI: 10.1136/bmjgast-2021-000842] [Reference Citation Analysis]
5 Patrono D, Cussa D, Rigo F, Romagnoli R; Liver Machine Perfusion Survey Group. Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation. Artif Organs 2021. [PMID: 34460943 DOI: 10.1111/aor.14061] [Reference Citation Analysis]
6 Buchwald JE, Martins PN. Designer organs: The future of personalized transplantation. Artificial Organs 2022;46:180-90. [DOI: 10.1111/aor.14151] [Reference Citation Analysis]
7 Martins PN, Buchwald JE, Mergental H, Vargas L, Quintini C. The role of normothermic machine perfusion in liver transplantation. Int J Surg 2020;82S:52-60. [PMID: 32417462 DOI: 10.1016/j.ijsu.2020.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Martins PN, Rizzari MD, Ghinolfi D, Jochmans I, Attia M, Jalan R, Friend PJ; ILTS Special Interest Group “DCD, Preservation and Machine Perfusion”. Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus Guidelines. Transplantation 2021;105:796-815. [PMID: 33760791 DOI: 10.1097/TP.0000000000003573] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
9 Riveros S, Marino C, Ochoa G, Morales E, Soto D, Alegría L, Zenteno MJ, Brañes A, Achurra P, Rebolledo RA. Implementation and design of customized ex vivo machine perfusion. Analysis of its first results. Artif Organs 2021. [PMID: 34519358 DOI: 10.1111/aor.14060] [Reference Citation Analysis]